Four years ago, scientists from Google showed up on neuroscientist Steve Finkbeiner’s doorstep. They wanted to apply deep-learning approaches to biology. This technology article by Nature describes what happened next.
This article by Scientific American describes Katherine Pollard’s recent findings on noncoding regions of our genome and explores how they may be key to how our brains develop.
The Scientist highlights a new approach developed by Sheng Ding and his team using a form of CRISPR that activates rather than cuts DNA to convert embryonic mouse cells to induced pluripotent stem cells.
The Stem Cellar, CIRM
CIRM, California’s Stem Cell Agency, highlights the stem cell blog posts that were most popular with their readers in 2017. A story covering Todd McDevitt’s work made the list: Scientists make stem cell-derived nerve cells damaged in spinal cord injury.
Science360News, National Science Foundation
The National Science Foundation’s Science360News featured a recent study by Melanie Ott, which reveals that an antiaging protein—known for being activated by red wine—is involved in how cells in the immune system develop with age.
Watch the Spanish RTVE program “El Cazador de Cerebros” (Brain Hunter) to see Shinya Yamanaka discuss whether he thinks biomedicine could influence human evolution.
Nature took a tour through the most studied genes in biology. Among them is the apolipoprotein E (apoE) protein, which Robert Mahley spent years studying. He describes its importance and its link to Alzheimer’s disease.
San Francisco Chronicle
In an article by the San Francisco Chronicle, Deepak Srivastava comments on the long-anticipated stem cell–therapy guidelines recently unveiled by the US Food and Drug Administration.
Todd McDevitt talks about his work creating organoids and the challenges faced in manufacturing human tissues in this video series by Seeker.
HIV Plus Magazine
After nearly 40 years of HIV research, is total eradication edging closer to reality? Although the “Berlin Patient” was cured after a bone-marrow-supplied stem cell transplant, Warner C. Greene warns that such transplants can put patients at considerable risk.